Back to Screener

Healthcare

Biohaven Ltd.(BHVN)

Live Price

Offline

$15.50

+14.22% today

1Y Change

+8.16%

Window

Jun 25, 2025 โ†’ Jun 22, 2026

Market Cap
$1.03B
Revenue Growth
0.0%
EPS Growth
+26.1%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 25, 2025 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Biohaven Ltd. (BHVN) is a Healthcare stock with a market cap of $1.03B. The stock last traded around $15.50 and up 8.2% across the available one-year price window (Jun 25, 2025 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +26.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.1%, free cash flow -4.0% with operating margin 0.0% and ROIC -157.9%. Stock Foundry combines BHVN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 11, 2026, but the surprise data is still limited.

The setup is mixed rather than one-directional

Revenue is 0.0% and EPS is +26.1%, while operating margin sits near 0.0%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -4.6% over the next 5 trading days and finished higher after 1 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 11, 2026
โ€”+1.3%-6.5%+22.1%
2026
Mar 2, 2026
+0.8%-9.7%-13.5%-31.5%
2025
Nov 10, 2025
+14.1%+9.4%+6.2%+34.5%

Benchmark Edge

BHVN vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BHVN

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BHVN Max Drawdown

-56.99%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BHVN and SPY.

Calendar-year return history is still loading or unavailable.
BI

Company Overview

Biohaven Ltd.

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
11.1

Growth

Revenue
0.0%
EPS
+26.1%
Free Cash Flow
-4.0%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-866.5%
ROIC
-157.9%

Balance Sheet

Debt/Equity
2.16
Current Ratio
7.41

Earnings Reports

๐Ÿ“… Last reportedMay 11, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 11, 26
โ€”
Est -0.86
โ€”
โ€”
Est 294.2B
โ€”
โ€”
Mar 2, 26
โœ“
-1.21
Est -1.22
+0.8%
โ€”
Est 400.0B
โ€”
โ€”
Nov 10, 25
โœ“
-1.64
Est -1.91
+14.1%
โ€”
Est 375.1B
โ€”
โ€”
Aug 11, 25
โ€”
-1.94
Est -1.94
0.0%
โ€”
Est 412.6B
โ€”
โ€”
May 12, 25
โœ—
-2.17
Est -1.67
-29.9%
โ€”
Est โ€”
โ€”
โ€”
Mar 3, 25
โœ—
-1.85
Est -1.56
-18.6%
โ€”
Est โ€”
โ€”
โ€”
Nov 12, 24
โ€”
-1.70
Est -1.70
0.0%
โ€”
Est โ€”
โ€”
โ€”
Aug 8, 24
โœ—
-3.64
Est -1.72
-111.6%
โ€”
Est โ€”
โ€”
โ€”
May 9, 24
โœ—
-2.20
Est -1.50
-46.7%
โ€”
Est โ€”
โ€”
โ€”
Feb 29, 24
โœ—
-1.81
Est -1.41
-28.4%
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 23
โœ—
-1.50
Est -1.33
-12.8%
โ€”
Est โ€”
โ€”
โ€”
Jul 31, 23
โœ—
-1.32
Est -1.24
-6.5%
โ€”
Est โ€”
โ€”
โ€”
May 12, 23
โœ“
-1.03
Est -1.39
+25.9%
โ€”
Est โ€”
โ€”
โ€”
Mar 23, 23
โœ—
-3.32
Est -1.24
-167.7%
215079.0B
Est โ€”
โ€”
โ€”
Nov 9, 22
โœ“
-1.75
Est -2.53
+30.8%
โ€”
Est โ€”
โ€”
โ€”
Aug 5, 22
โœ—
-6.21
Est -2.79
-122.6%
215079.0B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.